WEKO3
アイテム
{"_buckets": {"deposit": "b1552179-831a-4e37-b594-228172679e1b"}, "_deposit": {"created_by": 6, "id": "27351", "owners": [6], "pid": {"revision_id": 0, "type": "depid", "value": "27351"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00027351", "sets": ["11"]}, "author_link": ["121703", "121707", "121708", "121698", "121701", "121704", "121705", "121700", "121706", "121699", "121702"], "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2022-04-15", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "8", "bibliographicPageEnd": "1270", "bibliographicPageStart": "1265", "bibliographicVolumeNumber": "61", "bibliographic_titles": [{"bibliographic_title": "Internal medicine"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "A 49-year-old Japanese man with a 2-month history of a fever, headache, and bilateral conjunctival hyperemia was admitted. His condition fulfilled the giant cell arteritis classification criteria (new headache, temporal artery tenderness, elevated ESR) and atypical Cogan’s syndrome (CS) with scleritis and sensorineural hearing loss (SNHL). The interleukin (IL)-6 serum level was extremely high. Two weeks after his insufficient response of SNHL and scleritis to oral prednisolone, we administered tocilizumab (TCZ); rapid improvements in scleritis and SNHL occurred. Early IL-6 target therapy can help prevent irreversible CS-induced sensory organ damage.", "subitem_description_type": "Abstract"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "Internal medicine, 61(8), pp1265-1270; 2022", "subitem_description_type": "Other"}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Japanese Society of Internal Medicine"}]}, "item_2_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.2169/internalmedicine.7674-21", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "Ⓒ 2022 The Japanese Society of Internal Medicine The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/ by-nc-nd/4.0/)."}]}, "item_2_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "13497235", "subitem_source_identifier_type": "ISSN"}]}, "item_2_text_62": {"attribute_name": "出版者別言語", "attribute_value_mlt": [{"subitem_text_value": "日本内科学会"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Hara, Kazusato"}], "nameIdentifiers": [{"nameIdentifier": "121698", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Umeda, Masataka"}], "nameIdentifiers": [{"nameIdentifier": "121699", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Segawa, Keiko"}], "nameIdentifiers": [{"nameIdentifier": "121700", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Akagi, Midori"}], "nameIdentifiers": [{"nameIdentifier": "121701", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Endo, Yushiro"}], "nameIdentifiers": [{"nameIdentifier": "121702", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Koga, Tomohiro"}], "nameIdentifiers": [{"nameIdentifier": "121703", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kawashiri, Shin-ya"}], "nameIdentifiers": [{"nameIdentifier": "121704", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ichinose, Kunihiro"}], "nameIdentifiers": [{"nameIdentifier": "121705", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakamura, Hideki"}], "nameIdentifiers": [{"nameIdentifier": "121706", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Maeda, Takahiro"}], "nameIdentifiers": [{"nameIdentifier": "121707", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kawakami, Atsushi"}], "nameIdentifiers": [{"nameIdentifier": "121708", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2022-05-02"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "IM61_1265.pdf", "filesize": [{"value": "752.0 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 752000.0, "url": {"label": "IM61_1265.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/27351/files/IM61_1265.pdf"}, "version_id": "8590526b-1f73-4808-b5c9-055f1b8d204c"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Cogan’s syndrome", "subitem_subject_scheme": "Other"}, {"subitem_subject": "giant cell arteritis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "interleukin-6", "subitem_subject_scheme": "Other"}, {"subitem_subject": "tocilizumab", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Atypical Cogan’s Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Atypical Cogan’s Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab"}]}, "item_type_id": "2", "owner": "6", "path": ["11"], "permalink_uri": "http://hdl.handle.net/10069/00041490", "pubdate": {"attribute_name": "公開日", "attribute_value": "2022-05-02"}, "publish_date": "2022-05-02", "publish_status": "0", "recid": "27351", "relation": {}, "relation_version_is_last": true, "title": ["Atypical Cogan’s Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab"], "weko_shared_id": -1}
Atypical Cogan’s Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab
http://hdl.handle.net/10069/00041490
http://hdl.handle.net/10069/000414902160d158-b211-4672-807c-c4933530ab2b
名前 / ファイル | ライセンス | アクション |
---|---|---|
IM61_1265.pdf (752.0 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2022-05-02 | |||||
タイトル | ||||||
タイトル | Atypical Cogan’s Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Cogan’s syndrome | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | giant cell arteritis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | interleukin-6 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | tocilizumab | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Hara, Kazusato
× Hara, Kazusato× Umeda, Masataka× Segawa, Keiko× Akagi, Midori× Endo, Yushiro× Koga, Tomohiro× Kawashiri, Shin-ya× Ichinose, Kunihiro× Nakamura, Hideki× Maeda, Takahiro× Kawakami, Atsushi |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | A 49-year-old Japanese man with a 2-month history of a fever, headache, and bilateral conjunctival hyperemia was admitted. His condition fulfilled the giant cell arteritis classification criteria (new headache, temporal artery tenderness, elevated ESR) and atypical Cogan’s syndrome (CS) with scleritis and sensorineural hearing loss (SNHL). The interleukin (IL)-6 serum level was extremely high. Two weeks after his insufficient response of SNHL and scleritis to oral prednisolone, we administered tocilizumab (TCZ); rapid improvements in scleritis and SNHL occurred. Early IL-6 target therapy can help prevent irreversible CS-induced sensory organ damage. | |||||
書誌情報 |
Internal medicine 巻 61, 号 8, p. 1265-1270, 発行日 2022-04-15 |
|||||
出版者 | ||||||
出版者 | Japanese Society of Internal Medicine | |||||
出版者別言語 | ||||||
日本内科学会 | ||||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 13497235 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.2169/internalmedicine.7674-21 | |||||
権利 | ||||||
権利情報 | Ⓒ 2022 The Japanese Society of Internal Medicine The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/ by-nc-nd/4.0/). | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Internal medicine, 61(8), pp1265-1270; 2022 |